Search

Your search keyword '"Donofrio, Gaetano"' showing total 492 results

Search Constraints

Start Over You searched for: Author "Donofrio, Gaetano" Remove constraint Author: "Donofrio, Gaetano"
492 results on '"Donofrio, Gaetano"'

Search Results

5. Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations

6. A Simple and Versatile Method for Ex Vivo Monitoring of Goat Vaginal Mucosa Transduction by Viral Vector Vaccines.

10. Humoral Immune Response in Immunized Sheep with Bovine Coronavirus Glycoproteins Delivered via an Adenoviral Vector.

11. Vaccination of cattle with a virus-vectored vaccine against a major membrane protein of Mycobacterium a. subsp. paratuberculosis elicits CD8 cytotoxic T cells that kill intracellular bacteria

14. P-180 PYGO2 is upregulated in multiple myeloma patients with 1q21+: a potential novel therapeutic target

15. Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma

18. Characterization of BoHV-4 ORF45

25. Figure S5 from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

26. Abstract 6797: Oncolytic virotherapy with non-human viruses to improve anti-myeloma effect

27. Supplementary Methods from Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer

29. Indocyanine-enhanced mouse model of bleomycin-induced lung fibrosis with hallmarks of progressive emphysema

30. Indocyanine-enhanced mouse model of bleomycin-induced lung fibrosis with hallmarks of progressive emphysema

31. Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target

33. Characterization of BoHV-4 ORF45

34. Identification of the Proteasome Subunits PSMB4 and PSMD4 As Novel Targets in Multiple Myeloma Patients Carrying 1q21 Amplification

35. Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease

36. Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations

37. Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response

38. Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines

39. Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease.

44. Impact of Omicron variant on the response to SARS-CoV-2 mRNA vaccination in multiple myeloma and monoclonal gammopathies

46. PSMB4 and PSMD4 Are Correlated with 1q21 Amplification in CD138 + Plasma Cells: New Potential Druggable Targets in Myeloma Patients

47. Advances in Understanding of the Immune Response to Mycobacterial Pathogens and Vaccines through Use of Cattle and Mycobacterium avium subsp. paratuberculosis as a Prototypic Mycobacterial Pathogen

48. PYGO2-MDR1 Axis in Multiple Myeloma Patients with 1q21 Amplification As Promising Target to Overcome Carfilzomib Resistance

49. Persistency of Mesenchymal Stromal/Stem Cells in Lungs

50. Multimodality Approach to Characterizing the Distinctive Hallmarks of Lung Fibrosis: A Mouse Model with Bleomycin and Indocyanine Green

Catalog

Books, media, physical & digital resources